Splendris Pharmaceuticals GMBH

Splendris Pharmaceuticals GMBH is a drug manufacturer registered in Frankfurt, Germany. It is mainly engaged in the commercialization of cardiovascular, anti-infection and oncology drugs in the European Union market and the export of drugs to other markets outside Europe.

More

Splendris International Limited

This is a subsidiary of Shenzhen Salubris Pharmaceutical Co., Ltd., located in Hong Kong, China, with major business of trading and technological support service.

More

Salubris Biotherapeutics,Inc.

This is a subsidiary of Shenzhen Salubris Pharmaceutical Co., Ltd., located in Maryland, the United States, bringing together a number of well-known new drug experts who devote themselves to the early development of innovative drugs, carrying out the study of new bio-pharmaceuticals with global proprietary intellectual property rights, and gradually realizing the process from imitation to innovation and the leap forward from domestic declaration to simultaneous declaration in China, the United States and Europe to effectively enhance the global competitiveness of the Company in terms of innovative drug R&D.

More

Huizhou Salubris Pharmaceutical Co., Ltd.

This is a subsidiary of Shenzhen Salubris Pharmaceutical Co., Ltd., and a high-end biological medicine manufacturer integrating R&D, production and sales, committed to R&D and production of APIs forcardiovascular, cerebrovascular, antidiabetics, antineoplastics and anti-infection drugs.

More

Genekey Biotech (Chengdu) Co., Ltd.

This is a subsidiary of Shenzhen Salubris Pharmaceutical Co., Ltd., focusing on research and development of biotechnologically innovative drugs. It has established R&D platforms for three new drugs, i.e. recombinant protein, antibody-based and gene therapy drugs, and features a complete development chain for innovative drugs from new molecule design, process development, quality research and clinical research to industrial production. Under the topic of new drug development, it undertakes several key science and technology programs of the 11th and 12th Five-Year Plans of China, and has won honors including Sichuan Provincial First Prize for Progress in Science and Technology, and the National Prize for Progress in Science and Technology.

More

Genemen Biotech (Suzhou) Co., Ltd.

This is a subsidiary of Shenzhen Salubris Pharmaceutical Co., Ltd., mainly engaged in industrial development of biotechnological drugs. It has built Suzhou Engineering Technology Research Center for Recombinant Protein Medicine with products of recombinant protein and monoclonal antibody, covering the fields of tumor, tissue repair, digestive system diseases and autoimmune diseases. FlexFactory (industrial base) adopts the GE integrated solution and is built in strict compliance with EU GMP standards. Core members of the team are all expert in biological product development with over 20 years’ experience and were awarded to be innovation leading talents in Taicang City in 2010, leading talents in Suzhou City in 2011, and “entrepreneurship and innovation” talents in Jiangsu Province in 2011, and were included in Jiangsu Provincial Cultivation Program of “Six Talent Peaks” in 2012. They also undertook the special funded program for achievement transfer in Jiangsu Province in 2013 and were selected to the “entrepreneurship and innovation program” team in Jiangsu Province in 2015.

More

Shenzhen Salubris Biomedical Engineering Co., Ltd.

This is a subsidiary of Shenzhen Salubris Pharmaceutical Co., Ltd. It is mainly engaged in the R&D and production of the Class 3interventional medical devices and focuses on interventional cardiology and peripheral vascular areas. It has established Shenzhen CardiovascularDrug and Equipment Development Engineering Laboratory focusing on many projects including cardiovascular prevention, drug therapies and interventional medical devices, centering on the demand for comprehensive prevention and treatment of cardiovascular diseases. It has also built “Salubris Medical Tech Park” in Pingshan, Shenzhen, committed to creating a comprehensive development platform for cardiovascular drugs and interventional medical devices with unique features.

More

Alain Medical (Beijing) Co., Ltd.

This is a subsidiary of Shenzhen Salubris Pharmaceutical Co., Ltd. which is committed to the R&D and production of active/ non-active implantable medical devices.

More

Shenzhen Keyidun Biomedical Technology Co., Ltd.

This is a joint stock company of Shenzhen Salubris Biomedical Engineering Co., Ltd. focusing on the R&D and application promotion of nickel-titanium medical devices.

More

Shenzhen Jianshankang Pharmaceutical Co., Ltd.

This is a subsidiary of Shenzhen Salubris Pharmaceutical Co., Ltd. It is committed to providing professional, efficient and qualified products and services for upstream and downstream customers in the medial industry. It is mainly engaged in domestic wholesale and import and export business of bulk drugs, medical intermediates, pharmaceutic preparations, pharmaceutical packaging material, etc.

More

Shandong Salubris Pharmaceutical Co., Ltd.

This is a subsidiary of Shenzhen Salubris Pharmaceutical Co., Ltd., mainly engaged in the R&D, production and sales of cephalosporin medical intermediates and enzyme products. The Company continued to promote scientific and technological innovation, subdivide product structure and make a number of scientific and technological innovations. It is evaluated to be “Shandong Provincial High-tech Enterprise”, “Dezhou Municipal Technology Innovative Enterprise” and “Dezhou Municipal Cephalosporin Antibiotics Engineering Technology Research Center” by Dezhou Municipal Government.

More